- Drug Control Program
From: Department of Public Health, Drug Control Program and
Prescription Monitoring Program (PMP)
To: Massachusetts Registered Pharmacies
Date: April 1, 2020
Subject: COVID-19 – Waiver of Requirement for Pharmacies to Collect and Submit Customer ID Information to the Prescription Monitoring Program
The COVID-19 public health emergency continues to produce an extraordinary demand on the Commonwealth's healthcare system. In light of greater infection control concerns at the pharmacy counter and upon prescription delivery, and in order to protect the health of the public and pharmacy staff through use of appropriate social distancing measures, it has become challenging to collect customer identification and signatures in compliance with 105 CMR 700.012(A).
Effective immediately, the Massachusetts Drug Control Program is waiving the requirement in 105 CMR 700.012(A) for pharmacies to collect and report a patient ID and signature in association with dispensing a controlled substance or Additional Drug.
When submitting prescription data to the PMP, enter “COVID19” in place of the ID number in the AIR05 ASAP field (please refer to the PMP dispensing guide for instructions on each of the ASAP data fields). No other changes are required. If you have questions, please contact the PMP by email at firstname.lastname@example.org.
This waiver will remain in effect until the termination of the State of Emergency.
All applicable statutes, regulations and guidance not inconsistent with this document remain in effect.